Advances in prognostic models for osteosarcoma risk

被引:2
|
作者
Yao, Yi [1 ,2 ]
Wang, Dapeng [1 ]
Zheng, Li [1 ,2 ,4 ]
Zhao, Jinmin [1 ,2 ,3 ]
Tan, Manli [1 ,2 ,4 ]
机构
[1] Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanning 530021, Peoples R China
[4] Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; Risk -prognosis model; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; OVARIAN CANCERS; DNA METHYLATION; DOWN-REGULATION; UP-REGULATION; EXPRESSION; PROTEIN; INVASION; RECEPTORS;
D O I
10.1016/j.heliyon.2024.e28493
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The risk prognosis model is a statistical model that uses a set of features to predict whether an individual will develop a specific disease or clinical outcome. It can be used in clinical practice to stratify disease severity and assess risk or prognosis. With the advancement of large-scale secondgeneration sequencing technology, along Prognosis models for osteosarcoma are increasingly being developed as large-scale second-generation sequencing technology advances and clinical and biological data becomes more abundant. This expansion greatly increases the number of prognostic models and candidate genes suitable for clinical use. This article will present the predictive effects and reliability of various prognosis models, serving as a reference for their evaluation and application.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma
    Zhang, Minglei
    Liu, Yang
    Kong, Daliang
    JOURNAL OF BONE ONCOLOGY, 2021, 26
  • [12] Prognostic markers in osteosarcoma
    Bakhshi, Sameer
    Radhakrishnan, Venkatraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 271 - 287
  • [13] Development and Validation of Novel Prognostic Models for Immune-Related Genes in Osteosarcoma
    Li, Junqing
    Su, Li
    Xiao, Xing
    Wu, Feiran
    Du, Guijuan
    Guo, Xinjun
    Kong, Fanguo
    Yao, Jie
    Zhu, Huimin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [14] Advances in post-operative prognostic models for hepatocellular carcinoma
    He, Ziqin
    She, Xiaomin
    Liu, Ziyu
    Gao, Xing
    Lu, Lu
    Huang, Julu
    Lu, Cheng
    Lin, Yan
    Liang, Rong
    Ye, Jiazhou
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (03): : 191 - 206
  • [15] RECENT ADVANCES IN OSTEOSARCOMA IN CHILDHOOD
    TOUZET, P
    MERCKX, J
    TOURANI, JM
    GAZETTE MEDICALE, 1991, 98 (04): : 33 - 38
  • [16] Recent Advances in Mechanobiology of Osteosarcoma
    Adamopoulos, Christos
    Gargalionis, Antonios N.
    Piperi, Christina
    Papavassiliou, Athanasios G.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (02) : 232 - 236
  • [17] Advances in emerging drugs for osteosarcoma
    Hattinger, Claudia Maria
    Fanelli, Marilu
    Tavanti, Elisa
    Vella, Serena
    Ferrari, Stefano
    Picci, Piero
    Serra, Massimo
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) : 495 - 514
  • [18] Advances in Targeted Therapy for Osteosarcoma
    Zhou, Wenya
    Hao, Mengze
    Du, Xiaoling
    Chen, Kexin
    Wang, Guowen
    Yang, Jilong
    DISCOVERY MEDICINE, 2014, 17 (96) : 301 - 307
  • [19] Advances in differentiation therapy for osteosarcoma
    Chen, Yingqian
    Cao, Ji
    Zhang, Ning
    Yang, Bo
    He, Qiaojun
    Shao, Xuejing
    Ying, Meidan
    DRUG DISCOVERY TODAY, 2020, 25 (03) : 497 - 504
  • [20] A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma
    Ge, Zhanyong
    Song, Delei
    MEDICINE, 2022, 101 (50) : E32083